| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 155,742 | 117,342 | 93,831 | 122,281 | | Cost of Revenue | 101,386 | 81,547 | 71,521 | 87,578 | | | Gross Profit | 54,356 | 35,795 | 22,310 | 34,703 | | | Operating Expenses | | Research Development | 11,956 | 11,222 | 11,380 | 12,653 | | Selling General and Administrative | 9,297 | 8,494 | 8,731 | 12,285 | | Non Recurring | 1,291 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 33,103 | 16,078 | 2,199 | 9,765 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,770 | 2,224 | (4,585) | (25,758) | | Earnings Before Interest And Taxes | 35,582 | 18,302 | (2,386) | (15,993) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 35,582 | 18,302 | (2,386) | (15,993) | | Income Tax Expense | 11,646 | 6,093 | (829) | (5,628) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,937 | 12,209 | (1,557) | (10,365) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,937 | 12,209 | (1,557) | (10,365) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,937 | $12,209 | ($1,557) | ($10,365) |
|
0.31% Nasdaq 
0.05%
Income Statement
